Switching to adalimumab is effective in a case of neuro-Behçet's disease refractory to infliximab

Clinical and Experimental Rheumatology

Volumn 28, Issue 4 SUPPL. 60, 2010, Pages

  Leccese, P ^a   D'Angelo, S ^a   Padula, A ^a   Coniglio, G ^a,b   Olivieri, Ignazio ^a  

^a Madonna Delle Grazie Hospital of Matera   (Italy)

^b Ospedale Civile di Matera   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYCLOSPORIN; INFLIXIMAB; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADULT; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT RESPONSE; UVEITIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BEHCET SYNDROME; HUMANS; MALE; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78049388697     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. AL-ARAJI A, KIDD DP: Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 2009; 8: 192-204.
2. BELZUNEGUI J, LÓPEZ L, PANIAGUA I, INTXAUSTI JJ, MAÍZ O: Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease. Clin Exp Rheumatol 2008; 26 (Suppl. 50): S133-4
3. PIPITONE N, OLIVIERI I, PADULA A et al.: Infliximab for the treatment of neuro-Behçet's disease. A case series and review of the literature. Arthritis Rheum 2008; 59: 285-90.
4. OLIVIERI I, D'ANGELO S, PADULA A, LECCESE P, MENNILLO GA: Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept. Clin Exp Rheumatol 2009; 27 (Suppl. 53): S112.
5. HATEMI G, SILMAN A, BANG D et al.: EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008; 67: 1652-62.
6. SERKOVA NJ, CHRISTIANS U, BENET LZ: Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 2004; 4: 97-107.
7. AKMAN-DEMIR G, AYRANCI O, KURTUNCU M, VANLI EN, MUTLU M, TUGAL-TUTKUN I: Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement? Clin Exp Rheumatol 2008; 26 (Suppl. 50): S84-90.